The treatment improved cognition and reversed behavioral and psychological symptoms of dementia (BPSD)-like symptoms, protected from cell-death, decreased extracellular Aβ oligomers, and restored apolipoproteins E and J concentrations, whose levels are rather increased in the 3xTg-AD. The gene discussed is APOE; the disease is Alzheimer disease.